Cargando…
Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia
INTRODUCTION AND AIM: Interleukin-6 to lymphocyte (IL-6/Lym) ratio has been identified as a potential prognostic tool in patients with SARS-CoV2 related pneumonia. The aim of our study was to compare the prognostic power of IL-6/Lym ratio with other biomarkers in patients initially admitted in a non...
Autores principales: | Masotti, Luca, Grifoni, Elisa, Pelagalli, Giulia, Cioni, Elisa, Mattaliano, Chiara, Cioffi, Elisa, Maggi, Francesca, Pinto, Gabriele, Madonia, Elisa Maria, Micheletti, Irene, Gelli, Anna Maria Grazia, Ciambotti, Benedetta, Mannucci, Amanda, Bello, Roberta, Cei, Francesco, Dolenti, Silvia, Tarquini, Roberto, Montenora, Iolanda, Spina, Rosario, Vanni, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660176/ https://www.ncbi.nlm.nih.gov/pubmed/34920336 http://dx.doi.org/10.1016/j.intimp.2021.108435 |
Ejemplares similares
-
Trends of thrombo-inflammation biomarkers after Tocilizumab predict treatment failure better than scores in patients with severe SARS-CoV2 related respiratory failure
por: Masotti, Luca, et al.
Publicado: (2022) -
Interleukin-6 as prognosticator in patients with COVID-19
por: Grifoni, Elisa, et al.
Publicado: (2020) -
Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study)
por: Cei, Francesco, et al.
Publicado: (2022) -
Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study
por: Masotti, Luca, et al.
Publicado: (2022) -
A rapid and cost-effective diagnostic algorithm for the detection of SARS-CoV-2 infection in the emergency area by combining highly sensitive antigenic test and RT-PCR
por: Salvetti, Sara, et al.
Publicado: (2022)